|
|
|
| Yeast Extracts: Improving Expression | Application Note | Nu-Tek Biosciences | Yeast extract improves E. coli protein production by over 50%, boosts desired protein attributes 4X, and offers a secure animal-free nutrient source. |
|
|
| Accelerating CGT Development And Manufacturing | Webinar | Thermo Fisher Scientific | Learn how the following framework can accelerate your viral vector, CAR-T, and iPSC programs, reduce risk, and streamline your path from development to commercial manufacturing. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | We've acquired one of the industry's fastest-growing outsourcing conference franchises. We’re back in the live events business; that's great news. This new partnership also sets us to wondering: As an outsourcing industry, where in fact are we regarding in-person and virtual events? I asked my new colleagues, the co-founders of PharmaSource and CDMO Live conferences, Luke Bilton and Chris Kilbee. | |
|
|
|
By Arnaud Deladeriere, Ph.D., Cell&Gene Consulting Inc. | Industry is beginning to accept that allogeneic cell therapy spans categories, and success depends on aligning biology, regulation, and economics unique to each product. | |
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Kodak’s Eastman Business Park in Rochester was the focus of a recent editorial. But the man leading Kodak’s comeback, Jim Continenza, Chairman and CEO, is a topic unto himself. He’s as animated as any public-company CEO you’ll encounter. And he knows his audience; in his conversation with Chief Editor Louis Garguilo he says Kodak “has always supplied CDMOs and the industry with important chemicals.” Read his vigorous take on domestic manufacturing and other supply-chain topics. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| GMP Manufacturing Cycle Time Reduction | Case Study | CAI | Identifying process redundancies and enhancing visual management allows manufacturers to stabilize workflows. These data-driven improvements can decrease operational variability by nearly 50%. |
|
|
| How In-House CDMO Analytics Reduce Risk and Cost | Article | By Jani Yömaa and Andrés Guerrero, 3PBIOVIAN | Integrated analytical capabilities within a CDMO are increasingly preferred to overcome challenges associated with outsourcing analysis in biopharma development and manufacturing. |
|
|
|
| High‑Throughput Automation For Consistent Expression | Poster | By Samantha Davis, ElevateBio | A high‑throughput, automated RNA‑seq workflow maintains uniform gene‑expression profiles across wide RNA inputs, enabling consistent library quality and genomics on standard liquid‑handling platforms. |
|
|
|
|
| Solving The DNA Knock-In Problem | Article | Applied StemCell | An in‑depth exploration of why large, precise DNA knock‑ins limit cell therapy progress—and how site‑specific integration enables durable, scalable genetic engineering solutions. |
|
|
| Strategic Supply Chain Leadership: Driving Biopharma Growth | Article | By Alyssa Colón and Shefali Mitra, Thermo Fisher Scientific Bioproduction | Amid a volatile pharma supply chain, strategic sourcing is now critical. Prioritizing your raw material supply ensures operational continuity, consistent performance, compliance, and on-time delivery. |
|
|
| Challenges And Opportunities With Novel AAV Capsids | Webinar | Viralgen | Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness. |
|
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
